Dermatitis
📧 Sign up to get email alerts when something new happens for Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-11-25FDA Approved: HYDROCORTISONE — Original Application (Eywa Pharma Inc)
FDA approved HYDROCORTISONE from Eywa Pharma Inc under an Original Application (ANDA 217160). This entry documents the approval of a generic…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Epicutaneous Testing of Cosmetics for Skin Compatibility [NA]
A clinical trial evaluating epicutaneous testing of cosmetics for skin compatibility is currently recruiting, sponsored by Insel Gruppe AG a…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Prevalence of Skin Sensitization and Dermatitis Among Epoxy-exposed Workers in the Wind Turbine Industry.
A completed clinical trial assessing the prevalence of skin sensitization and dermatitis among epoxy-exposed workers in the wind turbine bla…
-
FDA approval · 2024-08-22FDA Approved: BETAMETHASONE VALERATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original ANDA for Betamethasone Valerate topical (Alembic Pharmaceuticals), a generic corticosteroid product for inflammator…
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs
Completed clinical trial comparing immune checkpoint inhibitors versus non-ICI therapies for cutaneous adverse events, including Stevens-Joh…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2024-06-11FDA Approved: HYDROCORTISONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a Supplemental Application for HYDROCORTISONE from Aurobindo Pharma Limited, typically indicating a label change for this gener…
-
FDA approval · 2024-05-29FDA Approved: HALCINONIDE TOPICAL SOLUTION — Original Application (INA Pharmaceutics Inc)
FDA approved the Original Application for halcinonide topical solution from INA Pharmaceutics Inc, a generic version.
-
FDA approval · 2024-04-30FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (The J. Molner Company LLC)
FDA approves a supplemental application for hydrocortisone butyrate (ANDA 209556) by The J. Molner Company LLC. The approval updates the pro…
-
FDA approval · 2024-04-10FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Aurobindo Pharma Limited)
FDA approved Betamethasone dipropionate topical from Aurobindo Pharma Limited under an original ANDA for inflammatory and pruritic corticost…
-
FDA approval · 2024-01-05FDA Approved: DEXAMETHASONE INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for DEXAMETHASONE INTENSOL from Hikma Pharmaceuticals USA, Inc., a dexamethasone product.
-
FDA approval · 2023-12-28FDA Approved: CLOBETASOL PROPIONATE ANDA — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original ANDA for clobetasol propionate topical from Macleods Pharmaceuticals Limited, enabling a generic version of th…
-
FDA approval · 2023-08-23FDA Approved: DESOXIMETASONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for desoximetasone from Padagis Israel Pharmaceuticals Ltd, finalizing an update to the approved AND…
-
FDA label_change · 2023-07-17FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for Betamethasone Dipropionate from Viona Pharmaceuticals Inc, typically reflecting labeling cha…
-
FDA approval · 2023-07-17FDA Approved: HYDROCORTISONE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for hydrocortisone by Aurobindo Pharma Limited, marking the first approval of this generic product.
-
FDA approval · 2023-04-18FDA Approved: BETAMETHASONE VALERATE — Original Application (Xiromed, LLC.)
FDA approved Xiromed, LLC's Betamethasone Valerate Foam as an original ANDA, establishing a generic version of betamethasone valerate foam f…
-
CLINICAL_TRIALS withdrawal · 2022-11-03Clinical Trial Update: Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis [Phase 3]
Phase 3 trial of association drugs in dermatitis was withdrawn from the study.
-
FDA approval · 2022-05-31FDA Approved: FLUOCINOLONE ACETONIDE OIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Fluocinonide Acetonide Oil from Rising Pharma Holdings, Inc., a topical corticosteroid produ…
-
FDA approval · 2022-02-18FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a…
-
FDA approval · 2022-02-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the original application for a generic clobetasol propionate topical product by Quagen Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475) [Phase 3]
Phase 3 trial assessing effectiveness and safety of desloratadine syrup in children with atopic dermatitis and dermatitis conditions; study …
-
FDA approval · 2021-11-04FDA Approved: HYDROCORTISONE VALERATE CREAM — Original Application (Encube Ethicals, Inc.)
FDA approved Hydrocortisone Valerate Cream by Encube Ethicals as an Original Application; a generic topical corticosteroid indicated for inf…
-
CLINICAL_TRIALS trial_result · 2021-09-20Clinical Trial Update: Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects [Phase 3]
Phase 3 trial evaluating PF-04965842 for moderate to severe atopic dermatitis (eczema) in patients aged 12 and older; completed with results…
-
FDA approval · 2021-08-17FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for a topical Nystatin and Triamcinolone Acetonide product from Macleods Pharmaceuticals Limited for t…
-
FDA approval · 2021-04-02FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Quagen Pharmaceuticals LLC)
FDA approved the Original Application for fluocinonide acetonide topical product. The generic is manufactured by Quagen Pharmaceuticals LLC.
-
FDA approval · 2021-03-31FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic's generic Nystatin and Triamcinolone Acetonide for topical treatment of candidal skin infections and inflammatory derma…